FindTrial
Sign In

Analysis of Prognostic Factors in Patients with Acral and Cutaneous Melanoma Undergoing Surgical Treatment

Analysis of Prognostic Factors in Patients with Acral and Cutaneous Melanoma Undergoing Surgical Treatment - Analysis of Prognostic Factors in Melanoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109961
Enrollment
Unknown
Registered
2025-09-28
Start date
2025-10-08
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melanoma

Interventions

Surgical Treatment Group:None

Sponsors

China-Japan Union Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Patients pathologically confirmed with primary acral lentiginous melanoma and cutaneous melanoma; 2.Patients who have undergone standardized surgical procedures, including wide local excision of the primary tumor, sentinel lymph node biopsy, and regional lymph node dissection.

Exclusion criteria

Exclusion criteria: 1.Patients with mucosal melanoma, melanoma of unknown primary origin, or ocular melanoma; 2.Patients with severely incomplete clinical or pathological information; patients with follow-up duration less than 3 months as of the last follow-up date.

Design outcomes

Primary

MeasureTime frame
Local Recurrence-Free Survival ;—

Secondary

MeasureTime frame
Recurrence-Free Survival ;Distant Metastasis-Free Survival ;Overall Survival ;—

Countries

China

Contacts

Public ContactWu Guangzhi

China-Japan Union Hospital of Jilin University

wuguangzhi@jlu.edu.cn+86 135 7899 5079

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026